nodes	percent_of_prediction	percent_of_DWPC	metapath
Orlistat—CYP3A4—Flunisolide—allergic rhinitis	0.0527	0.192	CbGbCtD
Orlistat—CYP3A4—Olopatadine—allergic rhinitis	0.0495	0.181	CbGbCtD
Orlistat—CYP3A4—Loratadine—allergic rhinitis	0.0302	0.11	CbGbCtD
Orlistat—CYP3A4—Montelukast—allergic rhinitis	0.0302	0.11	CbGbCtD
Orlistat—CYP3A4—Methylprednisolone—allergic rhinitis	0.0277	0.101	CbGbCtD
Orlistat—PLA2G7—IL1 and megakaryotyces in obesity—TLR1—allergic rhinitis	0.0259	0.26	CbGpPWpGaD
Orlistat—CYP3A4—Triamcinolone—allergic rhinitis	0.021	0.0764	CbGbCtD
Orlistat—PNLIP—exocrine gland—allergic rhinitis	0.0201	0.135	CbGeAlD
Orlistat—CYP3A4—Betamethasone—allergic rhinitis	0.018	0.0656	CbGbCtD
Orlistat—CYP3A4—Prednisolone—allergic rhinitis	0.0177	0.0647	CbGbCtD
Orlistat—CYP3A4—Hydrocortisone—allergic rhinitis	0.0168	0.0613	CbGbCtD
Orlistat—DAGLB—bronchus—allergic rhinitis	0.0121	0.0816	CbGeAlD
Orlistat—PNLIP—respiratory system—allergic rhinitis	0.0105	0.0704	CbGeAlD
Orlistat—CYP3A4—Dexamethasone—allergic rhinitis	0.0105	0.0381	CbGbCtD
Orlistat—ABHD12—eye—allergic rhinitis	0.00956	0.0643	CbGeAlD
Orlistat—ABHD16A—bronchus—allergic rhinitis	0.00919	0.0618	CbGeAlD
Orlistat—ABHD12—bronchus—allergic rhinitis	0.00862	0.0579	CbGeAlD
Orlistat—ABHD16A—trachea—allergic rhinitis	0.00826	0.0555	CbGeAlD
Orlistat—DAGLB—lung—allergic rhinitis	0.00783	0.0526	CbGeAlD
Orlistat—PLA2G7—IL1 and megakaryotyces in obesity—ICAM1—allergic rhinitis	0.00782	0.0785	CbGpPWpGaD
Orlistat—ABHD12—trachea—allergic rhinitis	0.00774	0.052	CbGeAlD
Orlistat—FASN—bronchus—allergic rhinitis	0.00723	0.0486	CbGeAlD
Orlistat—FASN—trachea—allergic rhinitis	0.00649	0.0436	CbGeAlD
Orlistat—PLA2G7—lung—allergic rhinitis	0.00632	0.0425	CbGeAlD
Orlistat—ABHD16A—lung—allergic rhinitis	0.00593	0.0399	CbGeAlD
Orlistat—PNLIP—lung—allergic rhinitis	0.00556	0.0374	CbGeAlD
Orlistat—ABHD12—lung—allergic rhinitis	0.00556	0.0374	CbGeAlD
Orlistat—PLA2G7—IL1 and megakaryotyces in obesity—NFKB1—allergic rhinitis	0.00495	0.0497	CbGpPWpGaD
Orlistat—FASN—lung—allergic rhinitis	0.00466	0.0314	CbGeAlD
Orlistat—PLA2G4A—respiratory system—allergic rhinitis	0.00422	0.0284	CbGeAlD
Orlistat—PLA2G4A—bronchus—allergic rhinitis	0.00348	0.0234	CbGeAlD
Orlistat—PLA2G4A—trachea—allergic rhinitis	0.00312	0.021	CbGeAlD
Orlistat—DAGLA—G alpha (q) signalling events—CYSLTR1—allergic rhinitis	0.00311	0.0312	CbGpPWpGaD
Orlistat—DAGLB—G alpha (q) signalling events—CYSLTR1—allergic rhinitis	0.00311	0.0312	CbGpPWpGaD
Orlistat—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—MS4A2—allergic rhinitis	0.00287	0.0288	CbGpPWpGaD
Orlistat—DAGLA—Gastrin-CREB signalling pathway via PKC and MAPK—CYSLTR1—allergic rhinitis	0.00278	0.0279	CbGpPWpGaD
Orlistat—DAGLB—Gastrin-CREB signalling pathway via PKC and MAPK—CYSLTR1—allergic rhinitis	0.00278	0.0279	CbGpPWpGaD
Orlistat—FASN—AMPK Signaling—ADIPOQ—allergic rhinitis	0.00256	0.0257	CbGpPWpGaD
Orlistat—PLA2G4A—lung—allergic rhinitis	0.00224	0.0151	CbGeAlD
Orlistat—DAGLB—G alpha (q) signalling events—TAC1—allergic rhinitis	0.00218	0.0219	CbGpPWpGaD
Orlistat—DAGLA—G alpha (q) signalling events—TAC1—allergic rhinitis	0.00218	0.0219	CbGpPWpGaD
Orlistat—DAGLA—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—allergic rhinitis	0.00195	0.0196	CbGpPWpGaD
Orlistat—DAGLB—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—allergic rhinitis	0.00195	0.0196	CbGpPWpGaD
Orlistat—PLA2G4A—Endothelins—CYSLTR1—allergic rhinitis	0.00187	0.0188	CbGpPWpGaD
Orlistat—DAGLA—Platelet activation, signaling and aggregation—IL5—allergic rhinitis	0.00177	0.0178	CbGpPWpGaD
Orlistat—DAGLB—Platelet activation, signaling and aggregation—IL5—allergic rhinitis	0.00177	0.0178	CbGpPWpGaD
Orlistat—PLA2G4A—Carbinoxamine—Diphenhydramine—allergic rhinitis	0.00161	0.221	CbGdCrCtD
Orlistat—DAGLA—GPCR downstream signaling—PTGDR2—allergic rhinitis	0.00113	0.0113	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—PTGDR2—allergic rhinitis	0.00113	0.0113	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—PTGDR2—allergic rhinitis	0.00103	0.0103	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—PTGDR2—allergic rhinitis	0.00103	0.0103	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—IL5—allergic rhinitis	0.000915	0.00919	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—IL5—allergic rhinitis	0.000915	0.00919	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—CYSLTR1—allergic rhinitis	0.000886	0.0089	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—CYSLTR1—allergic rhinitis	0.000886	0.0089	CbGpPWpGaD
Orlistat—PLA2G4A—Dexamethasone—Flunisolide—allergic rhinitis	0.000834	0.115	CbGdCrCtD
Orlistat—PLA2G4A—Betamethasone—Flunisolide—allergic rhinitis	0.000834	0.115	CbGdCrCtD
Orlistat—PLA2G4A—AGE/RAGE pathway—SMAD3—allergic rhinitis	0.000826	0.0083	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—CYSLTR1—allergic rhinitis	0.000805	0.00808	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—CYSLTR1—allergic rhinitis	0.000805	0.00808	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—CCL11—allergic rhinitis	0.000777	0.00781	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—CCL11—allergic rhinitis	0.000777	0.00781	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—TAC1—allergic rhinitis	0.000622	0.00625	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—TAC1—allergic rhinitis	0.000622	0.00625	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—PTGDR2—allergic rhinitis	0.000606	0.00608	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—PTGDR2—allergic rhinitis	0.000606	0.00608	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—IL5—allergic rhinitis	0.000578	0.00581	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—IL5—allergic rhinitis	0.000578	0.00581	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—TAC1—allergic rhinitis	0.000565	0.00567	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—TAC1—allergic rhinitis	0.000565	0.00567	CbGpPWpGaD
Orlistat—DAGLB—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	0.000529	0.00531	CbGpPWpGaD
Orlistat—DAGLA—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	0.000529	0.00531	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—IL5—allergic rhinitis	0.000525	0.00527	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—IL5—allergic rhinitis	0.000525	0.00527	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—PTGDR2—allergic rhinitis	0.000502	0.00504	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CYSLTR1—allergic rhinitis	0.000475	0.00477	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CYSLTR1—allergic rhinitis	0.000475	0.00477	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CCL11—allergic rhinitis	0.000459	0.00461	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CCL11—allergic rhinitis	0.000459	0.00461	CbGpPWpGaD
Orlistat—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—NFKB1—allergic rhinitis	0.000447	0.00449	CbGpPWpGaD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—IL5—allergic rhinitis	0.000446	0.00448	CbGpPWpGaD
Orlistat—PLA2G4A—Betamethasone—Hydrocortisone—allergic rhinitis	0.000432	0.0595	CbGdCrCtD
Orlistat—PLA2G4A—Dexamethasone—Hydrocortisone—allergic rhinitis	0.000432	0.0595	CbGdCrCtD
Orlistat—PLA2G4A—AGE/RAGE pathway—NFKB1—allergic rhinitis	0.00042	0.00422	CbGpPWpGaD
Orlistat—PLA2G4A—Betamethasone—Methylprednisolone—allergic rhinitis	0.000408	0.0561	CbGdCrCtD
Orlistat—PLA2G4A—Dexamethasone—Methylprednisolone—allergic rhinitis	0.000408	0.0561	CbGdCrCtD
Orlistat—PLA2G4A—Betamethasone—Dexamethasone—allergic rhinitis	0.000402	0.0552	CbGdCrCtD
Orlistat—PLA2G4A—Dexamethasone—Betamethasone—allergic rhinitis	0.000402	0.0552	CbGdCrCtD
Orlistat—PNLIP—Signaling Pathways—CYSLTR1—allergic rhinitis	0.000394	0.00396	CbGpPWpGaD
Orlistat—PLA2G4A—Betamethasone—Triamcinolone—allergic rhinitis	0.000392	0.054	CbGdCrCtD
Orlistat—PLA2G4A—Dexamethasone—Triamcinolone—allergic rhinitis	0.000392	0.054	CbGdCrCtD
Orlistat—PNLIP—Signaling Pathways—CCL11—allergic rhinitis	0.00038	0.00382	CbGpPWpGaD
Orlistat—PLA2G4A—Betamethasone—Prednisolone—allergic rhinitis	0.000364	0.05	CbGdCrCtD
Orlistat—PLA2G4A—Dexamethasone—Prednisolone—allergic rhinitis	0.000364	0.05	CbGdCrCtD
Orlistat—Urticaria—Montelukast—allergic rhinitis	0.000352	0.00075	CcSEcCtD
Orlistat—Headache—Loratadine—allergic rhinitis	0.000352	0.000749	CcSEcCtD
Orlistat—Body temperature increased—Montelukast—allergic rhinitis	0.000351	0.000746	CcSEcCtD
Orlistat—Abdominal pain—Montelukast—allergic rhinitis	0.000351	0.000746	CcSEcCtD
Orlistat—Sweating increased—Dexamethasone—allergic rhinitis	0.000351	0.000746	CcSEcCtD
Orlistat—Sweating increased—Betamethasone—allergic rhinitis	0.000351	0.000746	CcSEcCtD
Orlistat—Dizziness—Cetirizine—allergic rhinitis	0.00035	0.000744	CcSEcCtD
Orlistat—Haemoglobin—Prednisolone—allergic rhinitis	0.000347	0.000738	CcSEcCtD
Orlistat—Neuropathy peripheral—Triamcinolone—allergic rhinitis	0.000347	0.000738	CcSEcCtD
Orlistat—Neuropathy peripheral—Methylprednisolone—allergic rhinitis	0.000346	0.000736	CcSEcCtD
Orlistat—Haemorrhage—Prednisolone—allergic rhinitis	0.000345	0.000735	CcSEcCtD
Orlistat—Dizziness—Flunisolide—allergic rhinitis	0.000344	0.000732	CcSEcCtD
Orlistat—Haemoglobin—Hydrocortisone—allergic rhinitis	0.000339	0.000721	CcSEcCtD
Orlistat—Haemorrhage—Hydrocortisone—allergic rhinitis	0.000337	0.000717	CcSEcCtD
Orlistat—Vomiting—Cetirizine—allergic rhinitis	0.000336	0.000716	CcSEcCtD
Orlistat—Nausea—Loratadine—allergic rhinitis	0.000334	0.000711	CcSEcCtD
Orlistat—Rash—Cetirizine—allergic rhinitis	0.000334	0.00071	CcSEcCtD
Orlistat—DAGLB—Signaling Pathways—TAC1—allergic rhinitis	0.000334	0.00335	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—TAC1—allergic rhinitis	0.000334	0.00335	CbGpPWpGaD
Orlistat—Dermatitis—Cetirizine—allergic rhinitis	0.000333	0.000709	CcSEcCtD
Orlistat—Headache—Cetirizine—allergic rhinitis	0.000331	0.000705	CcSEcCtD
Orlistat—Vomiting—Flunisolide—allergic rhinitis	0.000331	0.000704	CcSEcCtD
Orlistat—Rash—Flunisolide—allergic rhinitis	0.000328	0.000698	CcSEcCtD
Orlistat—Dermatitis—Flunisolide—allergic rhinitis	0.000328	0.000697	CcSEcCtD
Orlistat—Hypersensitivity—Montelukast—allergic rhinitis	0.000327	0.000695	CcSEcCtD
Orlistat—Headache—Flunisolide—allergic rhinitis	0.000326	0.000693	CcSEcCtD
Orlistat—Haemoglobin—Triamcinolone—allergic rhinitis	0.000319	0.000679	CcSEcCtD
Orlistat—Haemoglobin—Methylprednisolone—allergic rhinitis	0.000318	0.000677	CcSEcCtD
Orlistat—Asthenia—Montelukast—allergic rhinitis	0.000318	0.000677	CcSEcCtD
Orlistat—Haemorrhage—Triamcinolone—allergic rhinitis	0.000318	0.000676	CcSEcCtD
Orlistat—Haemorrhage—Methylprednisolone—allergic rhinitis	0.000317	0.000674	CcSEcCtD
Orlistat—Pharyngitis—Triamcinolone—allergic rhinitis	0.000315	0.00067	CcSEcCtD
Orlistat—Neuropathy peripheral—Betamethasone—allergic rhinitis	0.000315	0.000669	CcSEcCtD
Orlistat—Neuropathy peripheral—Dexamethasone—allergic rhinitis	0.000315	0.000669	CcSEcCtD
Orlistat—Nausea—Cetirizine—allergic rhinitis	0.000314	0.000669	CcSEcCtD
Orlistat—Pruritus—Montelukast—allergic rhinitis	0.000314	0.000668	CcSEcCtD
Orlistat—DAGLA—Signaling Pathways—IL5—allergic rhinitis	0.00031	0.00311	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—IL5—allergic rhinitis	0.00031	0.00311	CbGpPWpGaD
Orlistat—Nausea—Flunisolide—allergic rhinitis	0.000309	0.000657	CcSEcCtD
Orlistat—Immune system disorder—Hydrocortisone—allergic rhinitis	0.000305	0.000648	CcSEcCtD
Orlistat—Diarrhoea—Montelukast—allergic rhinitis	0.000304	0.000646	CcSEcCtD
Orlistat—Mental disorder—Hydrocortisone—allergic rhinitis	0.000295	0.000629	CcSEcCtD
Orlistat—Malnutrition—Hydrocortisone—allergic rhinitis	0.000294	0.000625	CcSEcCtD
Orlistat—Dizziness—Montelukast—allergic rhinitis	0.000293	0.000624	CcSEcCtD
Orlistat—Haemoglobin—Betamethasone—allergic rhinitis	0.00029	0.000616	CcSEcCtD
Orlistat—Haemoglobin—Dexamethasone—allergic rhinitis	0.00029	0.000616	CcSEcCtD
Orlistat—Haemorrhage—Betamethasone—allergic rhinitis	0.000288	0.000613	CcSEcCtD
Orlistat—Haemorrhage—Dexamethasone—allergic rhinitis	0.000288	0.000613	CcSEcCtD
Orlistat—Immune system disorder—Methylprednisolone—allergic rhinitis	0.000286	0.000609	CcSEcCtD
Orlistat—Mediastinal disorder—Methylprednisolone—allergic rhinitis	0.000286	0.000607	CcSEcCtD
Orlistat—Vision blurred—Prednisolone—allergic rhinitis	0.000283	0.000603	CcSEcCtD
Orlistat—Vomiting—Montelukast—allergic rhinitis	0.000282	0.0006	CcSEcCtD
Orlistat—Rash—Montelukast—allergic rhinitis	0.00028	0.000595	CcSEcCtD
Orlistat—Dermatitis—Montelukast—allergic rhinitis	0.00028	0.000595	CcSEcCtD
Orlistat—Ill-defined disorder—Prednisolone—allergic rhinitis	0.000279	0.000593	CcSEcCtD
Orlistat—Headache—Montelukast—allergic rhinitis	0.000278	0.000591	CcSEcCtD
Orlistat—Mental disorder—Methylprednisolone—allergic rhinitis	0.000278	0.000591	CcSEcCtD
Orlistat—PNLIP—Signaling Pathways—TAC1—allergic rhinitis	0.000276	0.00278	CbGpPWpGaD
Orlistat—Malnutrition—Methylprednisolone—allergic rhinitis	0.000276	0.000587	CcSEcCtD
Orlistat—Angioedema—Prednisolone—allergic rhinitis	0.000275	0.000584	CcSEcCtD
Orlistat—DAGLB—Hemostasis—TGFB1—allergic rhinitis	0.000273	0.00274	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—TGFB1—allergic rhinitis	0.000273	0.00274	CbGpPWpGaD
Orlistat—Ill-defined disorder—Hydrocortisone—allergic rhinitis	0.000272	0.000579	CcSEcCtD
Orlistat—Malaise—Prednisolone—allergic rhinitis	0.000271	0.000577	CcSEcCtD
Orlistat—Dysgeusia—Triamcinolone—allergic rhinitis	0.000271	0.000576	CcSEcCtD
Orlistat—Vertigo—Prednisolone—allergic rhinitis	0.00027	0.000575	CcSEcCtD
Orlistat—Angioedema—Hydrocortisone—allergic rhinitis	0.000268	0.000571	CcSEcCtD
Orlistat—Back pain—Triamcinolone—allergic rhinitis	0.000267	0.000569	CcSEcCtD
Orlistat—Malaise—Hydrocortisone—allergic rhinitis	0.000265	0.000563	CcSEcCtD
Orlistat—Vertigo—Hydrocortisone—allergic rhinitis	0.000264	0.000561	CcSEcCtD
Orlistat—Nausea—Montelukast—allergic rhinitis	0.000264	0.000561	CcSEcCtD
Orlistat—Convulsion—Prednisolone—allergic rhinitis	0.00026	0.000554	CcSEcCtD
Orlistat—PNLIP—Disease—SMAD3—allergic rhinitis	0.000258	0.00259	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—PTGDR2—allergic rhinitis	0.000258	0.00259	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—IL5—allergic rhinitis	0.000257	0.00258	CbGpPWpGaD
Orlistat—Ill-defined disorder—Triamcinolone—allergic rhinitis	0.000256	0.000546	CcSEcCtD
Orlistat—Ill-defined disorder—Methylprednisolone—allergic rhinitis	0.000256	0.000544	CcSEcCtD
Orlistat—Alopecia—Dexamethasone—allergic rhinitis	0.000255	0.000542	CcSEcCtD
Orlistat—Alopecia—Betamethasone—allergic rhinitis	0.000255	0.000542	CcSEcCtD
Orlistat—Convulsion—Hydrocortisone—allergic rhinitis	0.000254	0.000541	CcSEcCtD
Orlistat—Discomfort—Prednisolone—allergic rhinitis	0.000253	0.000538	CcSEcCtD
Orlistat—Angioedema—Triamcinolone—allergic rhinitis	0.000253	0.000537	CcSEcCtD
Orlistat—Angioedema—Methylprednisolone—allergic rhinitis	0.000252	0.000536	CcSEcCtD
Orlistat—Myalgia—Hydrocortisone—allergic rhinitis	0.00025	0.000532	CcSEcCtD
Orlistat—Malaise—Triamcinolone—allergic rhinitis	0.000249	0.00053	CcSEcCtD
Orlistat—Anxiety—Hydrocortisone—allergic rhinitis	0.000249	0.00053	CcSEcCtD
Orlistat—Malaise—Methylprednisolone—allergic rhinitis	0.000249	0.000529	CcSEcCtD
Orlistat—Vertigo—Triamcinolone—allergic rhinitis	0.000248	0.000528	CcSEcCtD
Orlistat—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—allergic rhinitis	0.000248	0.000528	CcSEcCtD
Orlistat—Vertigo—Methylprednisolone—allergic rhinitis	0.000248	0.000527	CcSEcCtD
Orlistat—Discomfort—Hydrocortisone—allergic rhinitis	0.000247	0.000525	CcSEcCtD
Orlistat—Oedema—Prednisolone—allergic rhinitis	0.000245	0.000522	CcSEcCtD
Orlistat—Anaphylactic shock—Prednisolone—allergic rhinitis	0.000245	0.000522	CcSEcCtD
Orlistat—Cough—Triamcinolone—allergic rhinitis	0.000241	0.000513	CcSEcCtD
Orlistat—Anaphylactic shock—Hydrocortisone—allergic rhinitis	0.00024	0.00051	CcSEcCtD
Orlistat—Oedema—Hydrocortisone—allergic rhinitis	0.00024	0.00051	CcSEcCtD
Orlistat—Convulsion—Triamcinolone—allergic rhinitis	0.00024	0.00051	CcSEcCtD
Orlistat—Convulsion—Methylprednisolone—allergic rhinitis	0.000239	0.000508	CcSEcCtD
Orlistat—Infection—Hydrocortisone—allergic rhinitis	0.000238	0.000506	CcSEcCtD
Orlistat—Hyperhidrosis—Prednisolone—allergic rhinitis	0.000237	0.000505	CcSEcCtD
Orlistat—Myalgia—Triamcinolone—allergic rhinitis	0.000235	0.000501	CcSEcCtD
Orlistat—Nervous system disorder—Hydrocortisone—allergic rhinitis	0.000235	0.0005	CcSEcCtD
Orlistat—Myalgia—Methylprednisolone—allergic rhinitis	0.000235	0.0005	CcSEcCtD
Orlistat—Anxiety—Methylprednisolone—allergic rhinitis	0.000234	0.000498	CcSEcCtD
Orlistat—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—allergic rhinitis	0.000233	0.000496	CcSEcCtD
Orlistat—Skin disorder—Hydrocortisone—allergic rhinitis	0.000233	0.000495	CcSEcCtD
Orlistat—Ill-defined disorder—Dexamethasone—allergic rhinitis	0.000233	0.000495	CcSEcCtD
Orlistat—Ill-defined disorder—Betamethasone—allergic rhinitis	0.000233	0.000495	CcSEcCtD
Orlistat—Discomfort—Triamcinolone—allergic rhinitis	0.000233	0.000495	CcSEcCtD
Orlistat—Discomfort—Methylprednisolone—allergic rhinitis	0.000232	0.000494	CcSEcCtD
Orlistat—Hyperhidrosis—Hydrocortisone—allergic rhinitis	0.000232	0.000493	CcSEcCtD
Orlistat—Dry mouth—Triamcinolone—allergic rhinitis	0.00023	0.00049	CcSEcCtD
Orlistat—PLA2G4A—Hemostasis—IL5—allergic rhinitis	0.00023	0.00231	CbGpPWpGaD
Orlistat—Angioedema—Dexamethasone—allergic rhinitis	0.000229	0.000488	CcSEcCtD
Orlistat—Angioedema—Betamethasone—allergic rhinitis	0.000229	0.000488	CcSEcCtD
Orlistat—Malaise—Dexamethasone—allergic rhinitis	0.000226	0.000481	CcSEcCtD
Orlistat—Malaise—Betamethasone—allergic rhinitis	0.000226	0.000481	CcSEcCtD
Orlistat—Oedema—Triamcinolone—allergic rhinitis	0.000226	0.00048	CcSEcCtD
Orlistat—Anaphylactic shock—Triamcinolone—allergic rhinitis	0.000226	0.00048	CcSEcCtD
Orlistat—Vertigo—Betamethasone—allergic rhinitis	0.000225	0.000479	CcSEcCtD
Orlistat—Vertigo—Dexamethasone—allergic rhinitis	0.000225	0.000479	CcSEcCtD
Orlistat—Anaphylactic shock—Methylprednisolone—allergic rhinitis	0.000225	0.000479	CcSEcCtD
Orlistat—Infection—Triamcinolone—allergic rhinitis	0.000224	0.000477	CcSEcCtD
Orlistat—Infection—Methylprednisolone—allergic rhinitis	0.000224	0.000476	CcSEcCtD
Orlistat—Insomnia—Prednisolone—allergic rhinitis	0.000222	0.000472	CcSEcCtD
Orlistat—Nervous system disorder—Methylprednisolone—allergic rhinitis	0.000221	0.00047	CcSEcCtD
Orlistat—Paraesthesia—Prednisolone—allergic rhinitis	0.00022	0.000469	CcSEcCtD
Orlistat—Skin disorder—Methylprednisolone—allergic rhinitis	0.000219	0.000465	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Hydrocortisone—allergic rhinitis	0.000218	0.000464	CcSEcCtD
Orlistat—DAGLA—Signaling Pathways—SMAD3—allergic rhinitis	0.000218	0.00219	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—SMAD3—allergic rhinitis	0.000218	0.00219	CbGpPWpGaD
Orlistat—Hyperhidrosis—Triamcinolone—allergic rhinitis	0.000218	0.000464	CcSEcCtD
Orlistat—Hyperhidrosis—Methylprednisolone—allergic rhinitis	0.000218	0.000463	CcSEcCtD
Orlistat—Convulsion—Betamethasone—allergic rhinitis	0.000217	0.000462	CcSEcCtD
Orlistat—Convulsion—Dexamethasone—allergic rhinitis	0.000217	0.000462	CcSEcCtD
Orlistat—Insomnia—Hydrocortisone—allergic rhinitis	0.000217	0.000461	CcSEcCtD
Orlistat—Paraesthesia—Hydrocortisone—allergic rhinitis	0.000215	0.000458	CcSEcCtD
Orlistat—Myalgia—Dexamethasone—allergic rhinitis	0.000214	0.000454	CcSEcCtD
Orlistat—Myalgia—Betamethasone—allergic rhinitis	0.000214	0.000454	CcSEcCtD
Orlistat—Anxiety—Betamethasone—allergic rhinitis	0.000213	0.000453	CcSEcCtD
Orlistat—Anxiety—Dexamethasone—allergic rhinitis	0.000213	0.000453	CcSEcCtD
Orlistat—Discomfort—Dexamethasone—allergic rhinitis	0.000211	0.000449	CcSEcCtD
Orlistat—Discomfort—Betamethasone—allergic rhinitis	0.000211	0.000449	CcSEcCtD
Orlistat—Dyspepsia—Hydrocortisone—allergic rhinitis	0.000211	0.000449	CcSEcCtD
Orlistat—Pain—Prednisolone—allergic rhinitis	0.00021	0.000446	CcSEcCtD
Orlistat—Decreased appetite—Hydrocortisone—allergic rhinitis	0.000208	0.000443	CcSEcCtD
Orlistat—Gastrointestinal disorder—Hydrocortisone—allergic rhinitis	0.000207	0.00044	CcSEcCtD
Orlistat—Fatigue—Hydrocortisone—allergic rhinitis	0.000207	0.000439	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Triamcinolone—allergic rhinitis	0.000206	0.000437	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Methylprednisolone—allergic rhinitis	0.000205	0.000436	CcSEcCtD
Orlistat—Pain—Hydrocortisone—allergic rhinitis	0.000205	0.000436	CcSEcCtD
Orlistat—Oedema—Betamethasone—allergic rhinitis	0.000205	0.000435	CcSEcCtD
Orlistat—Oedema—Dexamethasone—allergic rhinitis	0.000205	0.000435	CcSEcCtD
Orlistat—Anaphylactic shock—Betamethasone—allergic rhinitis	0.000205	0.000435	CcSEcCtD
Orlistat—Anaphylactic shock—Dexamethasone—allergic rhinitis	0.000205	0.000435	CcSEcCtD
Orlistat—Insomnia—Triamcinolone—allergic rhinitis	0.000204	0.000434	CcSEcCtD
Orlistat—Insomnia—Methylprednisolone—allergic rhinitis	0.000204	0.000433	CcSEcCtD
Orlistat—Infection—Dexamethasone—allergic rhinitis	0.000203	0.000433	CcSEcCtD
Orlistat—Infection—Betamethasone—allergic rhinitis	0.000203	0.000433	CcSEcCtD
Orlistat—Paraesthesia—Triamcinolone—allergic rhinitis	0.000203	0.000431	CcSEcCtD
Orlistat—PLA2G4A—Signaling by GPCR—CYSLTR1—allergic rhinitis	0.000202	0.00203	CbGpPWpGaD
Orlistat—Feeling abnormal—Prednisolone—allergic rhinitis	0.000202	0.00043	CcSEcCtD
Orlistat—Paraesthesia—Methylprednisolone—allergic rhinitis	0.000202	0.00043	CcSEcCtD
Orlistat—Nervous system disorder—Dexamethasone—allergic rhinitis	0.000201	0.000427	CcSEcCtD
Orlistat—Nervous system disorder—Betamethasone—allergic rhinitis	0.000201	0.000427	CcSEcCtD
Orlistat—Dyspepsia—Triamcinolone—allergic rhinitis	0.000199	0.000422	CcSEcCtD
Orlistat—Dyspepsia—Methylprednisolone—allergic rhinitis	0.000198	0.000422	CcSEcCtD
Orlistat—Hyperhidrosis—Betamethasone—allergic rhinitis	0.000198	0.000421	CcSEcCtD
Orlistat—Hyperhidrosis—Dexamethasone—allergic rhinitis	0.000198	0.000421	CcSEcCtD
Orlistat—Feeling abnormal—Hydrocortisone—allergic rhinitis	0.000197	0.00042	CcSEcCtD
Orlistat—Gastrointestinal pain—Hydrocortisone—allergic rhinitis	0.000196	0.000417	CcSEcCtD
Orlistat—PLA2G4A—Signaling by GPCR—CCL11—allergic rhinitis	0.000196	0.00196	CbGpPWpGaD
Orlistat—Urticaria—Prednisolone—allergic rhinitis	0.000195	0.000415	CcSEcCtD
Orlistat—Fatigue—Triamcinolone—allergic rhinitis	0.000195	0.000414	CcSEcCtD
Orlistat—Fatigue—Methylprednisolone—allergic rhinitis	0.000194	0.000413	CcSEcCtD
Orlistat—Pain—Triamcinolone—allergic rhinitis	0.000193	0.00041	CcSEcCtD
Orlistat—Urticaria—Hydrocortisone—allergic rhinitis	0.00019	0.000405	CcSEcCtD
Orlistat—Body temperature increased—Hydrocortisone—allergic rhinitis	0.000189	0.000403	CcSEcCtD
Orlistat—Abdominal pain—Hydrocortisone—allergic rhinitis	0.000189	0.000403	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Dexamethasone—allergic rhinitis	0.000187	0.000397	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Betamethasone—allergic rhinitis	0.000187	0.000397	CcSEcCtD
Orlistat—Feeling abnormal—Triamcinolone—allergic rhinitis	0.000186	0.000396	CcSEcCtD
Orlistat—Feeling abnormal—Methylprednisolone—allergic rhinitis	0.000186	0.000395	CcSEcCtD
Orlistat—Insomnia—Dexamethasone—allergic rhinitis	0.000185	0.000394	CcSEcCtD
Orlistat—Insomnia—Betamethasone—allergic rhinitis	0.000185	0.000394	CcSEcCtD
Orlistat—Gastrointestinal pain—Methylprednisolone—allergic rhinitis	0.000184	0.000392	CcSEcCtD
Orlistat—Paraesthesia—Betamethasone—allergic rhinitis	0.000184	0.000391	CcSEcCtD
Orlistat—Paraesthesia—Dexamethasone—allergic rhinitis	0.000184	0.000391	CcSEcCtD
Orlistat—FASN—Disease—SMAD3—allergic rhinitis	0.000183	0.00184	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—SMAD3—allergic rhinitis	0.000181	0.00182	CbGpPWpGaD
Orlistat—Hypersensitivity—Prednisolone—allergic rhinitis	0.000181	0.000385	CcSEcCtD
Orlistat—Dyspepsia—Dexamethasone—allergic rhinitis	0.00018	0.000383	CcSEcCtD
Orlistat—Dyspepsia—Betamethasone—allergic rhinitis	0.00018	0.000383	CcSEcCtD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	0.000179	0.0018	CbGpPWpGaD
Orlistat—Urticaria—Triamcinolone—allergic rhinitis	0.000179	0.000381	CcSEcCtD
Orlistat—Urticaria—Methylprednisolone—allergic rhinitis	0.000179	0.00038	CcSEcCtD
Orlistat—Body temperature increased—Triamcinolone—allergic rhinitis	0.000178	0.000379	CcSEcCtD
Orlistat—Abdominal pain—Methylprednisolone—allergic rhinitis	0.000178	0.000379	CcSEcCtD
Orlistat—Decreased appetite—Betamethasone—allergic rhinitis	0.000178	0.000379	CcSEcCtD
Orlistat—Decreased appetite—Dexamethasone—allergic rhinitis	0.000178	0.000379	CcSEcCtD
Orlistat—Gastrointestinal disorder—Betamethasone—allergic rhinitis	0.000177	0.000376	CcSEcCtD
Orlistat—Gastrointestinal disorder—Dexamethasone—allergic rhinitis	0.000177	0.000376	CcSEcCtD
Orlistat—Hypersensitivity—Hydrocortisone—allergic rhinitis	0.000177	0.000376	CcSEcCtD
Orlistat—Fatigue—Dexamethasone—allergic rhinitis	0.000176	0.000375	CcSEcCtD
Orlistat—Fatigue—Betamethasone—allergic rhinitis	0.000176	0.000375	CcSEcCtD
Orlistat—Pain—Betamethasone—allergic rhinitis	0.000175	0.000372	CcSEcCtD
Orlistat—Pain—Dexamethasone—allergic rhinitis	0.000175	0.000372	CcSEcCtD
Orlistat—Asthenia—Hydrocortisone—allergic rhinitis	0.000172	0.000366	CcSEcCtD
Orlistat—Pruritus—Hydrocortisone—allergic rhinitis	0.00017	0.000361	CcSEcCtD
Orlistat—Feeling abnormal—Dexamethasone—allergic rhinitis	0.000169	0.000359	CcSEcCtD
Orlistat—Feeling abnormal—Betamethasone—allergic rhinitis	0.000169	0.000359	CcSEcCtD
Orlistat—Gastrointestinal pain—Betamethasone—allergic rhinitis	0.000167	0.000356	CcSEcCtD
Orlistat—Gastrointestinal pain—Dexamethasone—allergic rhinitis	0.000167	0.000356	CcSEcCtD
Orlistat—Hypersensitivity—Triamcinolone—allergic rhinitis	0.000166	0.000354	CcSEcCtD
Orlistat—Hypersensitivity—Methylprednisolone—allergic rhinitis	0.000166	0.000353	CcSEcCtD
Orlistat—Diarrhoea—Hydrocortisone—allergic rhinitis	0.000164	0.000349	CcSEcCtD
Orlistat—Urticaria—Betamethasone—allergic rhinitis	0.000163	0.000346	CcSEcCtD
Orlistat—Urticaria—Dexamethasone—allergic rhinitis	0.000163	0.000346	CcSEcCtD
Orlistat—Dizziness—Prednisolone—allergic rhinitis	0.000162	0.000345	CcSEcCtD
Orlistat—Asthenia—Triamcinolone—allergic rhinitis	0.000162	0.000344	CcSEcCtD
Orlistat—Body temperature increased—Betamethasone—allergic rhinitis	0.000162	0.000344	CcSEcCtD
Orlistat—Body temperature increased—Dexamethasone—allergic rhinitis	0.000162	0.000344	CcSEcCtD
Orlistat—Abdominal pain—Betamethasone—allergic rhinitis	0.000162	0.000344	CcSEcCtD
Orlistat—Abdominal pain—Dexamethasone—allergic rhinitis	0.000162	0.000344	CcSEcCtD
Orlistat—Asthenia—Methylprednisolone—allergic rhinitis	0.000162	0.000344	CcSEcCtD
Orlistat—Pruritus—Triamcinolone—allergic rhinitis	0.00016	0.00034	CcSEcCtD
Orlistat—Pruritus—Methylprednisolone—allergic rhinitis	0.000159	0.000339	CcSEcCtD
Orlistat—Dizziness—Hydrocortisone—allergic rhinitis	0.000158	0.000337	CcSEcCtD
Orlistat—Rash—Prednisolone—allergic rhinitis	0.000155	0.000329	CcSEcCtD
Orlistat—Dermatitis—Prednisolone—allergic rhinitis	0.000155	0.000329	CcSEcCtD
Orlistat—Diarrhoea—Methylprednisolone—allergic rhinitis	0.000154	0.000328	CcSEcCtD
Orlistat—Headache—Prednisolone—allergic rhinitis	0.000154	0.000327	CcSEcCtD
Orlistat—PLA2G4A—Signaling Pathways—PTGDR2—allergic rhinitis	0.000152	0.00153	CbGpPWpGaD
Orlistat—PNLIP—Disease—CD4—allergic rhinitis	0.000152	0.00153	CbGpPWpGaD
Orlistat—Vomiting—Hydrocortisone—allergic rhinitis	0.000152	0.000324	CcSEcCtD
Orlistat—Rash—Hydrocortisone—allergic rhinitis	0.000151	0.000321	CcSEcCtD
Orlistat—Dermatitis—Hydrocortisone—allergic rhinitis	0.000151	0.000321	CcSEcCtD
Orlistat—Headache—Hydrocortisone—allergic rhinitis	0.00015	0.000319	CcSEcCtD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	0.00015	0.0015	CbGpPWpGaD
Orlistat—Dizziness—Triamcinolone—allergic rhinitis	0.000149	0.000317	CcSEcCtD
Orlistat—Dizziness—Methylprednisolone—allergic rhinitis	0.000149	0.000317	CcSEcCtD
Orlistat—Asthenia—Dexamethasone—allergic rhinitis	0.000147	0.000312	CcSEcCtD
Orlistat—Asthenia—Betamethasone—allergic rhinitis	0.000147	0.000312	CcSEcCtD
Orlistat—Nausea—Prednisolone—allergic rhinitis	0.000146	0.00031	CcSEcCtD
Orlistat—Pruritus—Betamethasone—allergic rhinitis	0.000145	0.000308	CcSEcCtD
Orlistat—Pruritus—Dexamethasone—allergic rhinitis	0.000145	0.000308	CcSEcCtD
Orlistat—Vomiting—Triamcinolone—allergic rhinitis	0.000143	0.000305	CcSEcCtD
Orlistat—Vomiting—Methylprednisolone—allergic rhinitis	0.000143	0.000304	CcSEcCtD
Orlistat—Nausea—Hydrocortisone—allergic rhinitis	0.000142	0.000303	CcSEcCtD
Orlistat—Rash—Triamcinolone—allergic rhinitis	0.000142	0.000303	CcSEcCtD
Orlistat—Dermatitis—Triamcinolone—allergic rhinitis	0.000142	0.000302	CcSEcCtD
Orlistat—PLA2G4A—Signaling by GPCR—TAC1—allergic rhinitis	0.000142	0.00143	CbGpPWpGaD
Orlistat—Rash—Methylprednisolone—allergic rhinitis	0.000142	0.000302	CcSEcCtD
Orlistat—Dermatitis—Methylprednisolone—allergic rhinitis	0.000142	0.000302	CcSEcCtD
Orlistat—Headache—Triamcinolone—allergic rhinitis	0.000141	0.000301	CcSEcCtD
Orlistat—Headache—Methylprednisolone—allergic rhinitis	0.000141	0.0003	CcSEcCtD
Orlistat—Diarrhoea—Dexamethasone—allergic rhinitis	0.00014	0.000298	CcSEcCtD
Orlistat—Diarrhoea—Betamethasone—allergic rhinitis	0.00014	0.000298	CcSEcCtD
Orlistat—Dizziness—Dexamethasone—allergic rhinitis	0.000135	0.000288	CcSEcCtD
Orlistat—Dizziness—Betamethasone—allergic rhinitis	0.000135	0.000288	CcSEcCtD
Orlistat—Nausea—Triamcinolone—allergic rhinitis	0.000134	0.000285	CcSEcCtD
Orlistat—Nausea—Methylprednisolone—allergic rhinitis	0.000134	0.000284	CcSEcCtD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	0.000133	0.00134	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—IL5—allergic rhinitis	0.000132	0.00133	CbGpPWpGaD
Orlistat—Vomiting—Dexamethasone—allergic rhinitis	0.00013	0.000277	CcSEcCtD
Orlistat—Vomiting—Betamethasone—allergic rhinitis	0.00013	0.000277	CcSEcCtD
Orlistat—Rash—Dexamethasone—allergic rhinitis	0.000129	0.000275	CcSEcCtD
Orlistat—Rash—Betamethasone—allergic rhinitis	0.000129	0.000275	CcSEcCtD
Orlistat—Dermatitis—Dexamethasone—allergic rhinitis	0.000129	0.000274	CcSEcCtD
Orlistat—Dermatitis—Betamethasone—allergic rhinitis	0.000129	0.000274	CcSEcCtD
Orlistat—Headache—Betamethasone—allergic rhinitis	0.000128	0.000273	CcSEcCtD
Orlistat—Headache—Dexamethasone—allergic rhinitis	0.000128	0.000273	CcSEcCtD
Orlistat—Nausea—Betamethasone—allergic rhinitis	0.000122	0.000259	CcSEcCtD
Orlistat—Nausea—Dexamethasone—allergic rhinitis	0.000122	0.000259	CcSEcCtD
Orlistat—PLA2G4A—Signaling Pathways—CYSLTR1—allergic rhinitis	0.00012	0.0012	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CCL11—allergic rhinitis	0.000116	0.00116	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—NFKB1—allergic rhinitis	0.000111	0.00111	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—NFKB1—allergic rhinitis	0.000111	0.00111	CbGpPWpGaD
Orlistat—PNLIP—Disease—TGFB1—allergic rhinitis	0.000109	0.0011	CbGpPWpGaD
Orlistat—FASN—Disease—CD4—allergic rhinitis	0.000108	0.00108	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—TGFB1—allergic rhinitis	9.24e-05	0.000928	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—TGFB1—allergic rhinitis	9.24e-05	0.000928	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—NFKB1—allergic rhinitis	9.19e-05	0.000923	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—TAC1—allergic rhinitis	8.39e-05	0.000843	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—IL5—allergic rhinitis	7.8e-05	0.000784	CbGpPWpGaD
Orlistat—FASN—Disease—TGFB1—allergic rhinitis	7.74e-05	0.000777	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—TGFB1—allergic rhinitis	7.66e-05	0.000769	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—TGFB1—allergic rhinitis	6.86e-05	0.000689	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—SMAD3—allergic rhinitis	5.49e-05	0.000551	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—NFKB1—allergic rhinitis	2.79e-05	0.00028	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—TGFB1—allergic rhinitis	2.33e-05	0.000234	CbGpPWpGaD
